Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide plus atazanavir/ritonavir for COVID-19
PACTR202008855701534Phase 2Not yet recruiting
- Sponsor
- Obafemi Awolowo University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in coronavirus disease 2019 (COVID-19) comparing Nitazoxanide + atazanavir/ritonavir + standard of care with Standard of care (2 arms). Planned start Sep 2020; status: not yet recruiting.
02
Drugs
nitazoxanideatazanavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202008855701534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008855701534.